Superficial liposarcoma is a malignant adipose tumor located in subcutaneous or superficial soft tissue. Although much rarer than deep-seated liposarcomas, its clinical and radiological significance is high because differentiation from benign lipoma is critical. US is the primary evaluation modality and heterogeneous fat+solid component, thick septae (>2mm), and non-lipomatous component are suspicious findings. MRI is the gold standard for characterization. Subtypes include well-differentiated (atypical lipomatous tumor), dedifferentiated, myxoid, and pleomorphic.
Age Range
30-80
Peak Age
55
Gender
Equal
Prevalence
Rare
Liposarcoma results from malignant transformation of adipose tissue cells. Well-differentiated liposarcoma (atypical lipomatous tumor) is characterized by MDM2 and CDK4 gene amplification — this amplification is the diagnostic gold standard (confirmed by FISH or IHC). In well-differentiated liposarcoma, the tumor predominantly consists of mature fat but contains thick fibrous septae, non-adipose nodular areas, and atypical lipoblasts — on US, this heterogeneity is reflected as thick echogenic septae (>2mm) and solid hypoechoic areas. The non-lipomatous component represents non-adipose cell proliferation and appears as hypoechoic solid area on US — this finding is not seen in benign lipoma and is the most important indicator of malignancy suspicion. In myxoid liposarcoma, the tumor stroma contains myxoid matrix (hyaluronic acid-rich) — this myxoid component creates markedly hypoechoic appearance on US and low-density on CT, giving very bright signal on MRI T2. In dedifferentiated liposarcoma, a high-grade sarcoma area exists alongside the well-differentiated component — appearing as marked heterogeneity and solid vascular component on US.
Septae >2mm in thickness and/or hypoechoic non-lipomatous solid area within a lipomatous mass is the most important diagnostic clue for liposarcoma. In benign lipoma, septae are <2mm with no solid component. MRI characterization is mandatory when this finding is present.
On US, liposarcoma appears as a heterogeneous mass: hyperechoic fat areas coexist with hypoechoic non-lipomatous solid areas. This heterogeneity differs from the homogeneous fat structure of benign lipoma and is the most important US finding for malignancy suspicion. The non-lipomatous component appears as an irregularly marginated, hypoechoic solid area and may be focal or diffuse within the tumor.
Report Sentence
A heterogeneous mass containing hyperechoic areas consistent with fat and non-lipomatous hypoechoic solid areas is seen in the subcutaneous tissue; liposarcoma should be considered in the differential diagnosis.
Thick septae (>2mm) on US are an important finding raising suspicion for liposarcoma. Septae in benign lipoma are <2mm and thin; thickened septae reflect non-adipose tissue proliferation. Irregular thickness or nodular structure of septae further increases malignancy probability. Thick septae may consist of fibrosclerotic or neoplastic tissue.
Report Sentence
Septae >2mm in thickness are identified within the mass, a finding raising malignancy suspicion in lipomatous masses.
On color and power Doppler, internal vascularity may be detected within the non-lipomatous solid component of liposarcoma. Since benign lipoma is generally avascular, the presence of internal vascularity increases malignancy suspicion. Vascularity pattern may be irregular, mixed arterial-venous. Vascularity may also be seen within thick septae.
Report Sentence
Internal vascularity is identified within the solid component of the mass on power Doppler, increasing the possibility of malignancy in lipomatous lesions.
On MRI T1, liposarcoma contains fat-signal (hyperintense) areas with non-adipose T1 hypointense component. In well-differentiated liposarcoma, fat component is dominant with thick septae and focal non-adipose areas. In dedifferentiated liposarcoma, a prominent non-adipose solid component is present. Non-adipose areas show enhancement — this finding is best evaluated on fat-suppressed post-contrast sequences.
Report Sentence
A predominantly fat-signal mass with non-adipose hypointense component is seen on T1-weighted sequences; further evaluation is recommended with suspicion for liposarcoma.
On STIR sequences, fat components in liposarcoma are suppressed but non-adipose areas remain bright (hyperintense) — this incomplete suppression is the most important MRI finding for differentiation from lipoma. In benign lipoma, complete and homogeneous signal loss on STIR is expected; residual bright areas prove the presence of non-adipose component.
Report Sentence
Non-adipose areas remaining bright despite fat suppression on STIR sequences are seen within the mass, consistent with liposarcoma.
On contrast-enhanced CT, liposarcoma shows enhancing non-adipose component within fat-density areas. Thick septae and solid nodules may show enhancement. Enhancement of non-lipomatous component reflects neovascularization and indicates malignancy.
Report Sentence
An enhancing non-adipose solid component within a fat-density mass is seen on CT; liposarcoma should be considered in the differential diagnosis.
Criteria
MDM2/CDK4 amplification positive, predominant mature fat + thick septae + focal non-adipose areas
Distinct Features
Most common subtype. Local recurrence risk exists but does not metastasize. In superficial location, term 'atypical lipomatous tumor' is preferred because there is no metastatic potential. Treatment is wide surgical resection.
Criteria
DDIT3-FUS translocation, myxoid stroma dominant, minimal fat, markedly hypoechoic on US
Distinct Features
More common in young adults (30-50 years). Deep extremity (thigh) location typical. Very bright on MRI T2 due to high water content of myxoid component. Radiosensitive.
Criteria
High-grade sarcoma area alongside well-differentiated liposarcoma, MDM2/CDK4 amplification, prominent non-adipose solid component
Distinct Features
More aggressive, metastatic potential exists. Prominent solid component reflects dedifferentiation. Treatment is wide surgery + adjuvant therapy.
Distinguishing Feature
Benign lipoma shows complete homogeneous signal loss on STIR, septae <2mm, no non-adipose component or enhancement. Liposarcoma has incomplete suppression and non-adipose enhancing area.
Distinguishing Feature
Hematoma is avascular, shows time-dependent echogenicity change and is associated with trauma history. Liposarcoma has persistent solid component and vascularity.
Distinguishing Feature
Fibromatosis contains no fat signal (T1 hypointense, homogeneous), fascia-associated. Liposarcoma contains fat component and is heterogeneous.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
3-monthMRI characterization is mandatory when liposarcoma is suspected. Histopathologic diagnosis is required by core needle biopsy or excisional biopsy when non-adipose enhancing component is present. MDM2/CDK4 amplification (FISH or IHC) is the diagnostic gold standard. Treatment is wide surgical resection with negative surgical margins. Myxoid liposarcoma is radiosensitive. Local recurrence in well-differentiated liposarcoma may occur in 10-20%; follow-up MRI at 3-6 month intervals for first 2 years, then annually.
Liposarcomas have variable prognosis depending on subtype. Well-differentiated type tends to recur locally but has low metastatic risk. Dedifferentiated, myxoid, and pleomorphic types carry high metastatic risk. Biopsy is mandatory when solid component is detected in a fatty mass >5 cm. Wide surgical resection is the primary treatment.